Allspring Global Investments’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-198
Closed -$1.43K 2298
2024
Q3
$1.43K Sell
198
-48,610
-100% -$351K ﹤0.01% 2297
2024
Q2
$530K Buy
48,808
+176
+0.4% +$1.91K ﹤0.01% 1497
2024
Q1
$911K Sell
48,632
-6,956
-13% -$130K ﹤0.01% 1393
2023
Q4
$1.2M Sell
55,588
-3,205
-5% -$69.5K ﹤0.01% 1295
2023
Q3
$1.21M Sell
58,793
-43,850
-43% -$902K ﹤0.01% 1318
2023
Q2
$4.83M Buy
102,643
+8,200
+9% +$386K 0.01% 1013
2023
Q1
$3.96M Buy
94,443
+6,871
+8% +$288K 0.01% 1054
2022
Q4
$3.34M Sell
87,572
-9,961
-10% -$380K 0.01% 1095
2022
Q3
$3.82M Buy
97,533
+24,367
+33% +$954K 0.01% 1049
2022
Q2
$2.36M Sell
73,166
-1,260
-2% -$40.7K ﹤0.01% 1175
2022
Q1
$2.46M Sell
74,426
-1,811
-2% -$59.9K ﹤0.01% 1401
2021
Q4
$3.24M Buy
+76,237
New +$3.24M ﹤0.01% 1328